ライフサイエンスコーパス: -negative

1 was Prox1-positive, CD31-positive and LYVE-1-negative, bearing a different molecular signature from b

2 May and December, 2015, compared with mcr-1-negative isolates from rectal swabs of inpatients (colon

3 hese data, ACA11 overexpression in a t(4;14)-negative MM cell line, MM1.S, demonstrated enhanced reac

4 -1R, externally induced DNA damage in IGF-1R-negative cells caused G1 cell cycle arrest and S phase f

5 isk human epidermal growth factor receptor 2-negative breast cancer compared with the TC6 regimen.

6 145 human epidermal growth factor receptor 2-negative patients younger than 35 years in TEXT, 5-year

7 OG-ab NMOSD and 87.5% in the heterogenous ab-negative NMOSD cohort.

8 (Cohen d; Abeta-positive impaired vs. Abeta-negative normal) were evaluated in another phase 2 study

9 he adjacent matrix enriched with the ALDH1A1-negative axons.

10 risk TFs associated with ESR1-positive and -negative breast cancer can physically interact.

11 here mRNA from PGE2-G response-positive and -negative cell lines was subjected to transcriptome-wide

12 criminating between the cancer-positive and -negative cells, without any amplification step, in less

13 ilar 5-year EFS and OS for MRD-positive and -negative patients using an MRD threshold of 0.01%.

14 e growth of multiple AR-positive, but not AR-negative, prostate cancer cells.

15 hal in argininosuccinate synthetase 1 (ASS1)-negative cancers, including mesothelioma.

16 ist in finding a diagnosis for their autopsy-negative child SUD cases.

17 Five of 8 C4d-positive recipients turned C4d-negative in 5-week follow-up biopsies, while another 2 r

18 compared to cells infected with either cagA-negative or cag pathogenicity island (PAI) mutant.

19 Thus, calbindin-positive and calbindin-negative SNc neurons differ substantially in their calci

20 During inhibition, calbindin-negative neurons exhibit increased sensitivity to excita

21 increase excitation efficacy onto calbindin-negative cells during dopamine inhibition, suggesting th

22 divided into two populations: the calbindin-negative ventral tier, which is vulnerable to neurodegen

23 roduced by 243 isolates and 51 carbapenemase-negative isolates included porin mutants and producers o

24 Due to the highly challenging carbapenemase-negative isolates, specificities were lower than typical

25 ocytic leukaemia (CLL)-phenotype MBL and CD5-negative MBL, as well as differences in absolute monoclo

26 mal abnormalities in Philadelphia chromosome-negative (CCA/Ph(-)) metaphases emerge as patients with

27 icant differences were found between B2A-CIC-negative and control group patients.

28 If they are B2A-CIC-negative patients, they have the same risk as the contro

29 er serology, Bartonella serology) in culture-negative cases.

30 Defining the microbial etiology of culture-negative prosthetic joint infection (PJI) can be challen

31 lar-weight isoform of cyclin E (cytoplasmic)-negative) is a reliable prognostic biomarker in ER posit

32 ngs do not support the classification of DIF-negative patients, meeting the clinical criteria for ocu

33 all intent-to-treat minimal residual disease-negative (MRD(-)) remission rate for this phase 1 study

34 A dominant-negative (dn) atypical PKM selectively reversed associat

35 in the gene KCNA2, causing either a dominant-negative loss-of-function or a gain-of-function of the v

36 d that the mutated kinase acts in a dominant-negative manner to reduce CaMKIIalpha-WT autophosphoryla

37 Transgenic mice expressing a dominant-negative Orai1 mutant (E108Q) increases albuminuria, and

38 monolayers led to the proposal of a dominant-negative trafficking mechanism to explain AE1-associated

39 e, we show that overexpression of a dominant-negative version of DA1 enhances leaf size in a broad ra

40 such effects (gain of function and dominant-negative activity) in lung adenocarcinoma are unclear.

41 e of both pathways by Atg5(-/-) and dominant-negative rab5, ER cholesterol fails to increase when mTO

42 Wild-Type and dominant-negative-DISC1 (DN-DISC1) mice were injected with THC (1

43 Rather than being dominant-negative regulators, Tcf1 short isoforms are adequate in

44 OMPs that assemble slowly can form dominant-negative interactions with the Bam complex.

45 palmitoylated by GODZ using a GODZ dominant-negative plasmid.

46 We found that overexpression of dominant-negative (DN) forms of NSF or knockdown of the expressio

47 esized that selective expression of dominant-negative C-terminus-truncated human DISC1 (mutant DISC1)

48 tivity, whereas the introduction of dominant-negative NRF-1 repressed such activity.

49 ion and, contrary to their proposed dominant-negative role, did not interfere with the expression of

50 Here, we show that dominant-negative mutants of ATL1 in PC-12 cells inhibit nerve gr

51 ignaling by RNAi, expression of the dominant-negative Rac1 (Rac1 DN), or the specific Rac1 inhibitor

52 us transcription factors, including a double-negative feedback loop between the microRNA-200 (miR-200

53 h CAL-101 [idelalisib]), interrupts a double-negative feedback loop, enhancing GC-regulated transcrip

54 status (e.g., EGFR-positive [EGFR+] vs. EGFR-negative) was assessed using the Wilcoxon rank-sum test.

55 In ePET-negative patients, 5-year PFS rates in the F group were

56 In ePET-negative patients, noninferiority of ABVD only could not

57 We conducted a GWAS using 21,468 ER-negative cases and 100,594 controls combined with 18,908

58 10 of 11 variants previously reported in ER-negative disease or BRCA1 mutation carrier GWAS and obse

59 and observed consistent associations with ER-negative disease for 105 susceptibility variants identif

60 anti-hormone therapeutic efficacy in ERalpha-negative breast cancer.

61 tly inhibited breast tumor growth in ERalpha-negative mouse xenografts, especially when combined with

62 p are highly effective in inhibiting ERalpha-negative breast cancer due at least in part to epigeneti

63 False-negative results were found in 2 patients and occurred a

64 (PPV3), 30.4% (95% CI: 29.9%, 30.9%); false-negative rate, 4.8 per 1000 (95% CI: 4.6, 5.0); sensitiv

65 ive, true-negative, false-positive and false-negative patients as classified against any reference st

66 true- and false-positive and true- and false-negative results were extracted to fit a cross-tabulatio

67 ems associated with false-positive and false-negative results, inconsistencies and low reactivity of

68 rasitemia, and PfHRP-II tests can give false-negative results when P. falciparum strains do not expre

69 Seven of the 1982 patients (0.4%) had false-negative results with the staged algorithm.

70 higher analytic sensitivity and lower false-negative rate of HTS improves upon FC for MRD detection

71 test; Cepheid, Sunnyvale, CA) found no false-negative and 4 false-positive cobas Cdiff test results.

72 opriate antimicrobial therapy, with no false-negative cases.

73 There were no false-negative ratings.

74 s significantly lower expressed in PET false-negative cases (5.3-fold change, P < .001) which provide

75 levant number of patients with FDG-PET false-negative MM and a strong association between hexokinase-

76 However, the risk of PET false-negative results in the presence of carbidopa is a conce

77 cigarette use), indicating substantial false-negative rates.

78 test reliability, as indicated by the false-negative (FN), false-positive (FP), and fixation loss (F

79 ith human and porcine fVIII leading to false-negative HSM results.

80 mber of antimalarial treatments due to false-negative RDT results.

81 erformance and factors contributing to false-negative results in longitudinal studies, we examined re

82 ) version 2 score to better understand false-negative lesion characteristics.

83 owever, pfhrp2 gene deletions yielding false-negative RDTs, first reported in South America in 2010,

84 third of metastases < 1.0 cm were (18)F-FET-negative, most likely because of scanner resolution and

85 g cranial computed tomography-positive from -negative cases (AUC = 0.921, 0.923, and 0.646, respectiv

86 mice represent a novel mouse model of fusion-negative RMS.

87 Among the GCA-negative group, herpes zoster antigen was not detected i

88 METHODS AND A total of 160 AC genotype-negative probands for 5 AC desmosomal genes by conventio

89 cadherin 2 (CDH2) gene in unrelated genotype-negative patients with ARVC.

90 Gram-negative bacteria remodel their surfaces to interact wit

91 Gram-negative bacteria such as Escherichia coli are protected

92 Pseudomonas aeruginosa is a Gram-negative bacterial pathogen associated with acute and ch

93 regatibacter actinomycetemcomitans is a Gram-negative commensal bacterium of the oral cavity which ha

94 al activity, including activity against Gram-negative pathogens.

95 aureus and Streptococcus pyogenes) and gram-negative bacteria (Pseudomonas aeruginosa and Escherichi

96 ty against a panel of Gram-positive and Gram-negative bacteria revealed structure-activity relationsh

97 lin is active against Gram-positive and Gram-negative bacteria using a microdilution assay.

98 DR pathogens, such as malaria, HIV, and Gram-negative bacteria.

99 mensal and pathogenic Gram-positive and Gram-negative bacteria.

100 into the backbone of Gram-positive and Gram-negative bacterial PG utilizing metabolic cell wall recy

101 gram-positive Staphylococcus aureus and gram-negative Pseudomonas aeruginosa (99.3 +/- 1.9% and 88.5

102 Burkholderia cepacia complex (Bcc) are Gram-negative opportunisitic bacteria that are capable of cau

103 dal protein that limits contact between Gram-negative bacteria and the colonic epithelial surface.

104 four bacterial strains, including both Gram-negative and Gram-positive bacteria, showing great poten

105 ell-cell interactions between competing Gram-negative bacteria.

106 also relevant for other T3SS-containing Gram-negative bacteria.

107 tal of 210 Bactec bottles demonstrating Gram-negative bacilli were prospectively enrolled for this st

108 understand morphology in the dimorphic Gram-negative bacterium Caulobacter crescentus.

109 e zauPzapA operon is present in diverse Gram-negative bacteria, indicating a common mechanism for Z-r

110 in the extracellular matrix of enteric Gram-negative bacteria.

111 ultidrug resistant bacteria, especially Gram-negative bacteria for which the situation is particularl

112 and showed that HFM increases rat fecal Gram-negative bacteria, elevates lipopolysaccharides (LPS), a

113 exes constitute a primary mechanism for Gram-negative bacteria to expel toxic molecules for survival.

114 e, we chose the pilus protein FimG from Gram-negative bacteria and a disulfide-bonded variant of the

115 Mechanisms of drug resistance in gram-negative bacteria (GNB) are numerous; beta-lactamase gen

116 otein H-NS is a key global regulator in Gram-negative bacteria and is believed to be a crucial player

117 In Gram-negative bacteria, efflux pumps are able to prevent effe

118 velopment of resistance particularly in Gram-negative bacteria, illustrates the urgent need for new m

119 In Gram-negative bacteria, some of these pumps form multi-protei

120 arrel outer membrane proteins (OMPs) in Gram-negative bacteria.

121 e of Type Vd secreted phospholipases in Gram-negative bacteria.

122 timicrobial resistance, particularly in Gram-negative hospital pathogens, which has led to renewed ef

123 ella spp. are facultative intracellular Gram-negative bacteria that cause the zoonotic disease brucel

124 e and human RELMbeta selectively killed Gram-negative bacteria by forming size-selective pores that p

125 fective permeability barrier that makes Gram-negative bacteria inherently resistant to many antibioti

126 of novel therapeutic options to manage Gram-negative infections.

127 sociated with secretion systems in many Gram-negative and Gram-positive bacteria.

128 tilization of enterobactin permits many Gram-negative bacteria to thrive in environments where low so

129 Many Gram-negative bacteria use type 2 secretion systems (T2SSs) t

130 In many Gram-negative bacteria, including Rhodobacter capsulatus, cyt

131 nalool-IC-NFs inhibited growth of model Gram-negative (E. coli) and Gram-positive (S. aureus) bacteri

132 posed of 15 conserved proteins in model gram-negative species.

133 scriminate between viable and nonviable Gram-negative bacteria to tune the immune response, thereby l

134 rthfield, IL) for the identification of Gram-negative bacilli.

135 rapidly traverse the outer membrane of Gram-negative bacteria and accumulate inside these cells, mak

136 Although a number of Gram-negative bacteria are known to catabolize quinate and sh

137 The cell envelope of gram-negative bacteria, a structure comprising an outer (OM)

138 e gene exchange between five species of Gram-negative bacteria, and that the identity of the genetic

139 ad antibiotic resistance, especially of Gram-negative bacteria, has become a severe concern for human

140 r detecting lipopolysaccharide (LPS) of Gram-negative bacteria, was immobilized on both a large area

141 xcellent sensitivity to trace levels of Gram-negative bacteria, while remaining insensitive to both G

142 the space between the two membranes of Gram-negative bacteria.

143 roteins into the outer membrane (OM) of Gram-negative bacteria.

144 The outer membrane (OM) of Gram-negative is a unique lipid bilayer containing LPS in its

145 aratus functions in the injectisomes of gram-negative pathogens to export virulence factors into host

146 olysaccharide, a cell wall component of Gram-negative Proteobacteria and known inducer of lupus in mi

147 he difference in mechanism of action on gram-negative and gram-positive bacteria may be less pronounc

148 Antimicrobial resistance in pathogenic gram-negative bacteria is one of the most pressing challenges

149 Many pathogenic Gram-negative bacteria use the type III secretion system (T3S

150 Pseudomonas aeruginosa is a pathogenic gram-negative organism that has the ability to cause blinding

151 ibility profiles of clinically relevant Gram-negative bacteria within two hours of antibiotic introdu

152 r the prevention of multidrug-resistant gram-negative bacteria (MDR-GNB) in adult intensive care unit

153 Bcc) are a group of multidrug-resistant gram-negative bacteria rarely reported in patients without cy

154 Colonization by resistant gram-negative bacteria was significantly associated with an i

155 associated with antimicrobial-resistant Gram-negative pathogens.

156 and export of amyloid protein sequences.Gram-negative bacteria assemble biofilms from amyloid fibres,

157 evelopment for the treatment of serious Gram-negative infections.

158 Twenty-one small Gram-negative motile coccobacilli were isolated from 15 syste

159 ns are widespread in toxins that target Gram-negative bacteria.

160 The mission of the Gram-Negative Committee is to advance our knowledge of these

161 we have addressed this question in the Gram-negative model bacterium Burkholderia thailandensis E264

162 Bioinformatic screens reveal that these gram-negative bacteria carry genes coding for thiol-disulfide

163 3 ligase (NEL) domain that is unique to Gram-negative pathogens and whose activity is repressed by a

164 t Ags, and they are more susceptible to Gram-negative sepsis.

165 a low light dose (0.6 J cm(-2) ) toward Gram-negative bacteria E. coli, making it a remarkably effici

166 am-positive rods and other uncultivable Gram-negative rods, and, rarely, opportunistic microorganisms

167 I secretion (T2S) is one means by which Gram-negative pathogens secrete proteins into the extracellul

168 sing candidate to treat infections with Gram-negative bacteria.

169 nical needs in treating infections with Gram-negative bacteria.

170 n monocytes isolated from patients with Gram-negative sepsis compared with healthy control subjects.

171 We identified 85863 HCV-positive and HCV-negative men in the PSM population.

172 Among 1391 initially HCV-negative participants followed prospectively (1644.5 per

173 an epidermal growth factor receptor 2 (HER2)-negative tumors, 82.8% of luminal B-like HER2-positive t

174 esistant, hormone receptor-positive and HER2-negative advanced breast cancer.

175 ogenic contributions of EVI1 in ER- and HER2-negative subsets of breast cancer.

176 ependent data set, 2 of 9 (22.2%) ERBB2/HER2-negative BrCa switched to ERBB2/HER2-positive with 1 BrM

177 ing AGTR1 overexpression in a subset of HER2-negative breast cancers, and they provide a mechanistic

178 HER2 gene amplification and HER2-low or HER2-negative breast cancers following radiotherapy or endocr

179 d metastatic hormone receptor-positive, HER2-negative breast cancer.

180 ly confirmed hormone-receptor-positive, HER2-negative, locally advanced or metastatic breast cancer,

181 patient has hormone receptor-positive, HER2-negative, node-positive breast cancer, the MammaPrint as

182 In hormone receptor-positive/HER2-negative (n = 318) disease, BCSS was 100% in patients wi

183 (HGF-positive, MET-positive) and MKN45 (HGF-negative, MET-positive) and 4 patient-derived xenografts

184 ebo-controlled double-blind study of 162 HIV-negative RV144 vaccine recipients, we evaluated 2 additi

185 We studied these factors in 168 HIV-negative South African adolescent females aged 16 to 22

186 or specimens from 23 HIV-positive and 17 HIV-negative patients (29 men and 11 women; mean [SD] age, 5

187 Among 6751 HIV-negative HHCs with baseline blood samples, 192 had secon

188 0.008, -0.01 to -0.004; p=0.001) than in HIV-negative people, but the magnitudes of difference were s

189 were detected in both partners in 60% of HIV-negative couples and 96% of HIV-positive couples over 2

190 ral therapy (ART) is approaching that of HIV-negative people.

191 separate clinical studies of high-risk, HIV-negative persons conducted in Botswana and Thailand.

192 numbers of circulating CD4+ cells in the HIV-negative (HIV-) brain-dead donor (BDD) is not known.

193 overall life expectancies than did their HIV-negative counterparts in the general population [29.1 ye

194 ncerns for nephrotoxicity also extend to HIV-negative individuals using tenofovir disoproxil fumarate

195 ctions by comparing newly diagnosed with HIV-negative participants.

196 Human papillomavirus (HPV)-negative oropharyngeal squamous cell carcinoma (OPSCC) h

197 ermined based on 8 (6 HPV-positive and 2 HPV-negative) control samples.

198 ing cT1-2 N1-2b pathologically confirmed HPV-negative OPSCC in 2010 to 2012 were identified using the

199 ted redundancy for NSD family members in HPV-negative HNSCCs and suggest a potential role for impaire

200 ing chromatin regulators is warranted in HPV-negative HNSCCs driven by aberrant H3K36 methylation.

201 me deregulation in the genesis of 13% of HPV-negative HNSCCs.

202 all survival rates than do patients with HPV-negative HNSCC, but the mechanisms underlying this pheno

203 lts with infection-positive versus infection-negative systemic inflammation.

204 racing confirmed that LDB1-depleted, insulin-negative beta cells express NEUROG3 but do not adopt alt

205 dies were performed in PD-L1-positive, PD-L1-negative, and mixed tumor-bearing severe combined immuno

206 with Hirshfeld charges shows that the least-negative Cl discriminates active from nonactive substrat

207 Furthermore, lotus tetragonolobus lectin-negative/p-Creb-positive cyst segments (re)-expressed Nc

208 2(-/-) or Rag2(-/-)gammac(-/-) These lineage-negative CD45(+)/Thy1.2(+) cells are found within the my

209 liferated normally in vitro, whereas lineage-negative progenitors displayed impaired NK-cell differen

210 herapy for AS (58% vs 22%, P < 0.01), margin-negative resection (100% vs 73%, P < 0.01), reconstructi

211 in a subset analysis of patients with margin-negative resection (HR, 0.97; 95% CI, 0.66-1.45; P = .88

212 nalysis of peripheral blood B cells of 30 MC-negative HCV-infected patients and 15 healthy controls r

213 FDA microscopy-negative bacteria in these pretreatment samples may be a

214 and endocervical cells transfected with miR-negative control, miR-143 or miR-145 were used in cell p

215 ant patients have worse outcomes than FC MRD-negative patients.

216 Conclusion Our results demonstrate that MRD-negative status surpasses the prognostic value of CR ach

217 Twelve pre-surgical TLE patients (7 MRI-negative) and age-matched healthy volunteers were scanne

218 Mutation-negative patients therefore either have distinct disease

219 CLP (NME1 R18Q in an IRF6 and GRHL3 mutation-negative patient with van der Woude syndrome and NME2 G7

220 In the cohort of patients with node-negative disease, the 3-year rate of invasive-disease-fr

221 Non-negative Matrix Factorization (NMF) algorithms associate

222 We proposed a non-negative matrix factorization based method to rank, so a

223 ariate resolution curve fitting known as non-negative matrix factorization with alternating least-squ

224 were classified as HER2-positive (HER2+) or -negative (HER2-) based on fluorescence in situ hybridiza

225 We estimated panel-negative binomial models on a subset of beneficiaries to

226 1) or 3 (cohort 2) cycles of weekly BV; PET-negative patients (Deauville score </=2) proceeded to au

227 d significantly higher CT densities than PET-negative LNs, irrespective of the type of cancer.

228 g PfHRP2-only RDTs in the presence of PfHRP2-negative parasites caused an increase in prevalence, red

229 cribed in adult Philadelphia chromosome (Ph)-negative B-cell precursor (BCP) acute lymphoblastic leuk

230 Philadelphia chromosome (Ph)-positive or Ph-negative B-cell acute lymphoblastic leukaemia who were d

231 HCM after family screening, 74 FG+/phenotype-negative relatives, and 9 with noncompaction or dilated

232 ed as phenotype-positive (n=72) or phenotype-negative (n=102).

233 ce harboring PSMA-positive CWR22Rv1 and PSMA-negative PC-3 tumor xenografts.

234 aP and PC-3 (prostate cancer cell line; PSMA-negative) tumors.

235 reated with antimalarials (n = 104), (2) RDT-negative children whose untreated P. falciparum infectio

236 % of RDT-positive (n = 185) and 31.2% of RDT-negative samples (n = 340) were available and selected f

237 In estrogen receptor-negative (ER(-)) and triple-negative breast cancer (TNBC

238 eterogeneity = .10) versus estrogen receptor-negative disease.

239 ositive cancer and 63% for estrogen receptor-negative progesterone- receptor-negative cancer.

240 re similar among women with hormone receptor-negative disease, although the HRs were substantially sm

241 ormone receptor-positive vs hormone receptor-negative), nodal status (0 vs 1-3 vs or >/=4 positive no

242 ositive disease and 36% had hormone-receptor-negative disease.

243 gen receptor-negative progesterone- receptor-negative cancer.

244 ontribute to the pathogenesis of retinopathy-negative CM.

245 ribution of malaria infection to retinopathy-negative CM.

246 evere respiratory syncytial virus/rhinovirus-negative wheezing episode (adjusted OR, 8.0; P = .001),

247 candidate gene sequencing in additional SBDS-negative SDS cases or molecularly undiagnosed IBMFS case

248 trio whole-exome sequencing (WES) in an sbds-negative SDS family and candidate gene sequencing in add

249 n D deficiency is potentially causal of sero-negative RA and provide new insights into the pathogenes

250 ciation study (vGWAS) of six cohorts of sero-negative RA recruited in Europe and the US that were gen

251 The remaining three DSM265-treated, TBS-negative participants of cohort 2 developed transient su

252 rter was stringently repressed in telomerase-negative human cells in a histone deacetylase (HDAC)-dep

253 pdm09 and 305 B(Victoria) cases and 926 test-negative controls.

254 ion strategies to identify pathogens in test-negative children with CAP and asymptomatic controls.

255 Triple-negative (TN) breast cancer (BC) shares histological cha

256 Triple-negative breast cancer (TNBC) comprises approximately 20

257 Triple-negative breast cancer (TNBC) is a breast cancer subtype

258 Triple-negative breast cancer (TNBC) is an aggressive disease l

259 Triple-negative breast cancer (TNBC) patients commonly exhibit

260 Triple-negative breast cancer is viewed clinically as an aggres

261 Triple-negative breast cancer, compared with non-TNBC, likely a

262 Triple-negative breast cancers (TNBC) are highly aggressive, la

263 Triple-negative breast cancers (TNBCs) are more common among Af

264 strogen receptor-negative (ER(-)) and triple-negative breast cancer (TNBC), nitric oxide synthase-2 (

265 like tumors (24% v 8%; P < .001), and triple-negative tumors (21% v 6%; P = .08), but not for human e

266 owed a significant difference between triple-negative breast cancer and non-triple-negative breast ca

267 New treatments for triple-negative breast cancer (TNBC) are urgently needed.

268 s supporting AKT-targeted therapy for triple-negative breast cancer.

269 luding regression in PDX samples from triple-negative breast cancer.

270 he effects of elevated LDL-C in human triple-negative (MDA-MB-231) and mouse Her2/Neu-overexpressing

271 in a mouse orthotopic model of human triple-negative breast cancer.

272 een reported to be a driving force in triple-negative breast cancer (TNBC), contributing to the maint

273 tially lower level than Akt3/+S472 in triple-negative breast cancer cells, specific ablation of Akt3/

274 of tumor-infiltrating lymphocytes in triple-negative breast cancers and while MEK inhibition can pro

275 yields potent synthetic lethality in triple-negative breast tumors and other aggressive tumors chara

276 We show that, in triple-negative-breast cancer (TNBC) cells enriched with TICs,

277 by many aggressive cancers, including triple-negative breast cancers (TNBC), to utilize glutamine for

278 le stratification of mesenchymal-like triple-negative breast cancer (TNBC) cells that differ from one

279 JNK is highly activated in basal-like triple-negative breast cancer (TNBC).

280 Purpose Trop-2, expressed in most triple-negative breast cancers (TNBCs), may be a potential targ

281 In fact, most triple-negative breast cancers are poor-prognosis tumors with a

282 triple-negative breast cancer and non-triple-negative breast cancer (P = .009, .003, and .001, respec

283 involvement of ECs in the process of triple-negative breast cancer (TNBC) metastasis has not been ad

284 wledge related to the pathogenesis of triple-negative breast cancer.

285 iew, we describe the heterogeneity of triple-negative disease, focusing on the histologic and molecul

286 of HER2-enriched tumors, and 7.8% of triple-negative tumors.

287 in for patients with HER2-positive or triple-negative subtypes and extracranial metastases.

288 er patients, those diagnosed with the triple-negative breast cancer (TNBC) subtype have the worst pro

289 Among them, triple-negative breast cancer MDA-MB-231, which has the highest

290 Results Eighteen tumors (22%) were triple-negative breast cancers.

291 to be obese and to be diagnosed with triple-negative breast cancer (TNBC).

292 A signaling is highly correlated with triple-negative breast cancer (TNBC).

293 d/allowed calculation of true-positive, true-negative, false-positive and false-negative patients as

294 nd TBR in positive lobes compared with tumor-negative lobes.

295 wn tissue was composed of normal-sized, UCP1-negative unilocular adipocytes, with mitochondrial netwo

296 ting mutations in SMIM1 defines the rare Vel-negative phenotype.

297 immunodeficiency virus and hepatitis D virus-negative patients with pretransplant HBV DNA undetectabl

298 are not driven by MCPyV and that such virus-negative MCCs, which can be quite reliably identified by

299 2 (19%) MCC tumors in this cohort were virus-negative using this multimodal system.

300 state (differentiation) happened via an XIST-negative XaXa intermediate.